Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges

Neoadjuvant Treatment for Triple Negative Breast Cancer: Recent Progresses and Challenges

Triple negative breast cancer (TNBC) is an aggressive breast cancer with historically poor outcomes, primarily due to the lack of effective targeted therapies. The tumor molecular heterogeneity of TNBC has been well recognized, yet molecular subtype driven therapy remains lacking. While neoadjuvant...

Full description

Bibliographic Details
Main Authors: Jin Sun Lee, Susan E. Yost, Yuan Yuan
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cancers
Subjects:
Triple negative breast cancer
neoadjuvant treatment
targeted treatment
Online Access:https://www.mdpi.com/2072-6694/12/6/1404

Similar Items

Similar Items